To treat or not to treat: metabolomics reveals biomarkers for treatment indication in chronic lymphocytic leukaemia patients

In chronic lymphocytic leukaemia (CLL), the clinical course of patients is heterogeneous. Some present an aggressive disease onset and require immediate therapy, while others remain without treatment for years. Current disease staging systems developed by Rai and Binet may be useful in forecasting p...

Descripción completa

Detalles Bibliográficos
Autores principales: Piszcz, Jaroslaw, Armitage, Emily G., Ferrarini, Alessia, Rupérez, Francisco J., Kulczynska, Agnieszka, Bolkun, Lukasz, Kloczko, Janusz, Kretowski, Adam, Urbanowicz, Alina, Ciborowski, Michal, Barbas, Coral
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008363/
https://www.ncbi.nlm.nih.gov/pubmed/26988915
http://dx.doi.org/10.18632/oncotarget.8078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008363/
https://www.ncbi.nlm.nih.gov/pubmed/26988915
http://dx.doi.org/10.18632/oncotarget.8078

Ejemplares similares